drugset / Trial / NCT06368102

Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

NCT06368102

Phase 4 Completed 70 enrolled Uji Takeda Hospital
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine the incidence of surgical site infection (SSIs) after third molar surgery for different duration of intravenous ampicillin administration.

Timeline

Start
2024-05-02
Primary completion
2025-08-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ampicillin Unknown 1 g Intravenous

Indications

No indication recorded.